Authors:
Boyle, CD
Chackalamannil, S
Clader, JW
Greenlee, WJ
Josien, HB
Kaminski, JJ
Kozlowski, JA
McCombie, SW
Nazareno, DV
Tagat, JR
Wang, YG
Zhou, GW
Billard, W
Binch, H
Crosby, G
Cohen-Williams, M
Coffin, VL
Cox, KA
Grotz, DE
Duffy, RA
Ruperto, V
Lachowicz, JE
Citation: Cd. Boyle et al., Metabolic stabilization of benzylidene ketal M-2 muscarinic receptor antagonists via halonaphthoic acid substitution, BIOORG MED, 11(17), 2001, pp. 2311-2314
Authors:
Njoroge, FG
Vibulbhan, B
Wong, JK
White, SK
Wong, SC
Carruthers, NI
Kaminski, JJ
Doll, RJ
Girijavallabhan, V
Ganguly, AK
Citation: Fg. Njoroge et al., Synthesis of C-11 methyl-substituted benzocycloheptapyridine inhibitors offarnesyl protein transferase, ORG LETT, 1(9), 1999, pp. 1371-1373
Authors:
Kaminski, JJ
Carruthers, NI
Wong, SC
Chan, TM
Billah, MM
Tozzi, S
McPhail, AT
Citation: Jj. Kaminski et al., Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine, BIO MED CH, 7(7), 1999, pp. 1413-1423
Authors:
Piwinski, JJ
Wong, JK
Green, MJ
Kaminski, JJ
Colizzo, F
Albanese, MM
Ganguly, AK
Billah, MM
Anthes, JC
West, RE
Citation: Jj. Piwinski et al., Dual antagonists of platelet activating factor and histamine - 3. Synthesis, biological activity and conformational implications of substituted N-acyl-bis-arylcycloheptapiperazines., BIOORG MED, 8(24), 1998, pp. 3469-3474